SERA PROGNOSTICS INC-A
SERA · NASDAQ
更新于 2026-10-15 05:47:30
- 今日最高
- $2.07
- 今日最低
- $2.03
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
K线图趋势，实际资料以交易页为准
关键数据
- 昨日开盘价
- $2.03
- 昨日收盘价
- $2.07
- 成交量
- 5838
- 市值
- $8166.04万
- 本益比（P/E）
- --
- 每股收益（EPS）
- $-0.66
昨日价格区间
52周价格区间
公司概况
- 板块
- HEALTHCARE
- 行业
- Biotechnology
- 子行业
- MEDICAL DEVICES
- 总部
- 2749 EAST PARLEYS WAY, SALT LAKE CITY, UT, UNITED STATES, 84109
- 国家
- US
- 上市日期
- 2021-07-15
- 财年截止
- December
- 流通股数
- 3916万
- CIK
- 0001534969
- 官方网址
- www.sera.com
Sera Prognostics Inc. is a pioneering force in maternal-fetal health, focusing on cutting-edge diagnostic solutions designed to enhance pregnancy outcomes. Its flagship product, the PreTRM test, harnesses a unique biomarker platform to accurately evaluate the risk of preterm birth, enabling healthcare providers to implement timely and impactful interventions. With a steadfast commitment to advancing prenatal diagnostics and addressing pivotal health challenges, Sera is strategically positioned for significant growth within the maternal health sector, offering investors compelling opportunities for long-term value creation.
财务指标
营业收入
2026-06-30
$3万
2026-03-31
$1.4万
2025-12-31
$1万
2025-09-30
$1.6万
营业支出
2026-06-30
$998.4万
2026-03-31
$933.2万
2025-12-31
$892.2万
2025-09-30
$895.5万
净利润
2026-06-30
-$913.9万
2026-03-31
-$839.9万
2025-12-31
-$788.1万
2025-09-30
-$781.4万
净利润率
2026-06-30
-30.46K%
2026-03-31
-59.99K%
2025-12-31
-78.81K%
2025-09-30
-48.83K%
每股收益
2026-06-30
$-0.18
2026-03-31
$-0.17
2025-12-31
$-0.16
2025-09-30
$-0.16
息税折旧摊销前利润
2026-06-30
-$894.6万
2026-03-31
-$820.4万
2025-12-31
-$763.6万
2025-09-30
-$756.9万
有效税率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| 项目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 营业收入 | $3万 | $1.4万 | $1万 | $1.6万 |
| 营业支出 | $998.4万 | $933.2万 | $892.2万 | $895.5万 |
| 净利润 | -$913.9万 | -$839.9万 | -$788.1万 | -$781.4万 |
| 净利润率 | -30.46K% | -59.99K% | -78.81K% | -48.83K% |
| 每股收益 | $-0.18 | $-0.17 | $-0.16 | $-0.16 |
| 息税折旧摊销前利润 | -$894.6万 | -$820.4万 | -$763.6万 | -$756.9万 |
| 有效税率 | -- | -- | -- | -- |
常见问题
风险提示
股价可能大幅波动，短时间内可能出现显著涨跌。 数字资产与衍生品交易可能涉及杠杆、流动性等额外风险。 本页内容仅供参考，不构成任何投资建议。 产品可用性与访问可能因地区及适用法规而异。